| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/12/2002 | WO2002070697A1 Mammalian nuclear receptor l67 and methods of use |
| 09/12/2002 | WO2002070696A2 Cd109 nucleic acid molecules polypeptides and methods of use |
| 09/12/2002 | WO2002070695A2 Tumor associated proteins |
| 09/12/2002 | WO2002070694A2 Methods and compositions for modifying a receptor tyrosine kinase/protein tyrosine kinase signal to an apoptotic signal in a cell |
| 09/12/2002 | WO2002070693A2 Novel abca6 transporter and uses thereof |
| 09/12/2002 | WO2002070692A2 Abca9 transporter and uses thereof |
| 09/12/2002 | WO2002070691A2 Abcg4 transporter and uses thereof |
| 09/12/2002 | WO2002070690A2 Abca5 transporter and uses thereof |
| 09/12/2002 | WO2002070686A2 Cctra gene as a tool for the generation of a male progeny in the mediterranean fruitfly ceratitis capitata |
| 09/12/2002 | WO2002070681A1 Protein c variants |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070668A2 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 09/12/2002 | WO2002070667A2 High level insect expression of rage proteins |
| 09/12/2002 | WO2002070666A2 Compositions and methods for regulating autolytic processes in bacteria |
| 09/12/2002 | WO2002070665A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | WO2002070663A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/12/2002 | WO2002070661A2 Identification and characterization of a waxy curled leaf phenotype (wcl1) in arabidopsis |
| 09/12/2002 | WO2002070660A2 Proteins and nucleic acids encoding same |
| 09/12/2002 | WO2002070658A2 Compositions and methods for increasing amino acid absorption in mammals |
| 09/12/2002 | WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor |
| 09/12/2002 | WO2002070656A2 Dna encoding human cid1 |
| 09/12/2002 | WO2002070655A2 Mouse cytokine receptor |
| 09/12/2002 | WO2002070652A2 Novel molecules of the card-related protein family and uses thereof |
| 09/12/2002 | WO2002070651A2 Viral reporter particles |
| 09/12/2002 | WO2002070648A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 09/12/2002 | WO2002070647A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 09/12/2002 | WO2002070645A2 Functional surface display of polypeptides |
| 09/12/2002 | WO2002070565A2 High-affinity antagonists of elr-cxc chemokines |
| 09/12/2002 | WO2002070564A2 The guinea pig proteinase-activated receptor 4 and its activating peptide |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070556A1 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF |
| 09/12/2002 | WO2002070554A2 Dna encoding human cid2 |
| 09/12/2002 | WO2002070553A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | WO2002070552A2 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 09/12/2002 | WO2002070551A2 Neuritogenic compound and uses thereof |
| 09/12/2002 | WO2002070550A1 Fibroin powders and aqueous fibroin solutions for medical use |
| 09/12/2002 | WO2002070549A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | WO2002070548A2 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/12/2002 | WO2002070547A1 Template-fixed peptidomimetics with antimicrobial activity |
| 09/12/2002 | WO2002070546A2 Modified derivatives of cck-8 |
| 09/12/2002 | WO2002070542A2 Band 3 antigenic peptides, malaria polypeptides and uses thereof |
| 09/12/2002 | WO2002070539A2 Novel nucleic acids and polypeptides |
| 09/12/2002 | WO2002070538A2 Narc8 programmed cell-death-associated molecules and uses thereof |
| 09/12/2002 | WO2002070020A2 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 09/12/2002 | WO2002070019A1 Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension |
| 09/12/2002 | WO2002070018A2 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
| 09/12/2002 | WO2002070008A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | WO2002070006A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/12/2002 | WO2002070005A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 09/12/2002 | WO2002070004A2 Papillomavirus vaccines |
| 09/12/2002 | WO2002069999A1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 09/12/2002 | WO2002069997A1 Modified protamine with reduced immunogenicity |
| 09/12/2002 | WO2002069947A2 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer |
| 09/12/2002 | WO2002069907A2 Anti-neovasculature preparations for cancer |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002069885A2 Anti-invasive and anti-angiogenic compositions and methods for treating brain tumors and other diseases |
| 09/12/2002 | WO2002069884A2 A sunburn treatment and sunburn prevention method |
| 09/12/2002 | WO2002069840A2 Nucleic acids for transforming fish cells and methods for their use |
| 09/12/2002 | WO2002069691A2 Immunogenic hiv peptides for use as reagents and vaccines |
| 09/12/2002 | WO2002069689A2 Gssp4 polynucleotides and polypeptides and uses thereof |
| 09/12/2002 | WO2002062851A8 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 09/12/2002 | WO2002052274A3 Screening method based on tsap6 binding partners |
| 09/12/2002 | WO2002052012A3 Sugar beet genes involved in stress tolerance |
| 09/12/2002 | WO2002051865A3 Proteinic antigens inducing antibodies neutralising hiv virus |
| 09/12/2002 | WO2002050111A3 Isolated laminin 10 |
| 09/12/2002 | WO2002050103A3 Tumour-related antigens |
| 09/12/2002 | WO2002040500A3 Method of prognosis and diagnosis of congestive heart failure |
| 09/12/2002 | WO2002033067A3 Regulation of promoter activity using a polypeptide isolated from lactococcus lactis |
| 09/12/2002 | WO2002024722A3 Crystalline fgf9 dimer and methods of use |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 09/12/2002 | WO2002022652A8 Haplotypes of the slc18a2 gene |
| 09/12/2002 | WO2002016613A3 PEAR GENES CODIFYING FOR β-GALACTOSIDASE, PECTIN METHYLESTERASE, POLYGALACTURONASE, EXPANSINS AND THEIR USE |
| 09/12/2002 | WO2002016410A3 Peptide selection method |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2002012476A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 09/12/2002 | WO2002012346A3 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 09/12/2002 | WO2002008258A3 65494, a human g-protein-coupled receptor family member and uses thereof |
| 09/12/2002 | WO2002002622A3 Crystal structure of survivin |
| 09/12/2002 | WO2001098501A3 Hypersensitive response eliciting domains of bacterial harpins and use thereof |
| 09/12/2002 | WO2001093914A3 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 09/12/2002 | WO2001084921A3 Transgenic animal |
| 09/12/2002 | WO2001083529A3 Immunoadhesin for the prevention of rhinovirus infection |
| 09/12/2002 | WO2001081634A3 Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 |
| 09/12/2002 | WO2001077684A3 Proteomic analysis using activity-based probe libraries |
| 09/12/2002 | WO2001077354A3 Cell cycle stress-related proteins and methods of use in plants |
| 09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
| 09/12/2002 | WO2001077178A8 Compositions and methods for detection of von willebrand's disease |
| 09/12/2002 | WO2001077151A3 Fdrg proteins and nucleic acid molecules and uses therefor |
| 09/12/2002 | WO2001071346A3 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 09/12/2002 | WO2001066744A3 Human transporter proteins and polynucleotides encoding the same |
| 09/12/2002 | WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses |
| 09/12/2002 | WO2001042467A3 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 09/12/2002 | WO2001040519A3 Methods for identifying modulators for balance related disorders |
| 09/12/2002 | WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |